Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Mustafa Nuri YENEREL"'
Autor:
Shirkhan Amikishiyev, Sevgi Kalayoglu Besisik, Ipek Yonal Hindilerden, Mustafa Nuri Yenerel, Arif Atahan Cagatay, Simge Erdem, Gulkan Ozkan, Meliha Nalcaci, Deniz Sargin
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S37- (2023)
Objective: This study aimed to investigate the frequency of infections after autologous hematopoietic stem cell transplantation (HSCT) in patients who were diagnosed with multiple myeloma (MM) in our tertiary center. Methodology: We conducted a singl
Externí odkaz:
https://doaj.org/article/3f147dce0f584f36b1ede9ddfea89d1a
Autor:
Murat Özbalak, Metban Mastanzade, Dilek Özden Özlük, Tarık Onur Tiryaki, Simge Erdem, Ezgi Pınar Özbalak, Tuğrul Elverdi, İpek Yçnal Hindilerden, Ali Yılmaz Altay, Gülçin Yeğen, Ahmet Emre Eşkazan, Muhlis Cem Ar, Mustafa Nuri Yenerel, Teoman Soysal, Meliha Nalçacı, Burhan Ferhanoğlu, Sevgi Kalayoğlu Beşışık
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 4, Pp 254-261 (2022)
Objective: Redditux® (RED), as a biosimilar rituximab, was approved in Turkey for all indications of the original Mabthera® (MAB) in March 2018. The aim of our study was to evaluate the efficacy and safety of RED in de novo diffuse large B-cell lym
Externí odkaz:
https://doaj.org/article/2a9fff72faa5467abb4cb2fad80cdfb5
Autor:
Phillip Scheinberg, Diego Cle, John Edwards, Valentina Giai, Marek Hus, Jin Seok Kim, Cristina Barrenetxea Lekue, Zsolt Nagy, Erfan Nur, Jens Panse, Yasutaka Ueda, Mustafa Nuri Yenerel, Anita Appius, Nadiesh Balachandran, Sammy Chebon, Brittany Gentile, Simon Buatois, Austin Kulasekararaj
Publikováno v:
HemaSphere, Vol 7, p e45540d8 (2023)
Externí odkaz:
https://doaj.org/article/2d2502a5b31c44548849194a5c1b9631
Autor:
Hilal Konyaoglu, Ali Yilmaz Altay, Emine Göknur Işik, Beyza Oluk, Nigar Taghiyeva, Elif Sakci, Simge Erdem, Gülçin Yeğen, İpek Yönal Hindilerden, Mustafa Nuri Yenerel, Meliha Nalcaci, Sevgi Kalayoglu Besisik
Publikováno v:
HemaSphere, Vol 7, p e09840e4 (2023)
Externí odkaz:
https://doaj.org/article/8681a538aca2453e8063d447cb685277
Autor:
Fehmi Hindilerden, Ipek Yonal-Hindilerden, Mustafa Nuri Yenerel, Meliha Nalcaci, Reyhan Diz-Kucukkaya
Publikováno v:
Hematology Reports, Vol 14, Iss 3, Pp 222-227 (2022)
No data exist for the association between the presence of accessory spleen after splenectomy and response to rituximab in immune thrombocytopenia (ITP). We investigated the relationship between accessory spleen presence and rituximab response in sple
Externí odkaz:
https://doaj.org/article/68343ad2459a4a9a8115e3b707839d6d
Autor:
Simge ERDEM, Metban MASTANZADE, Mustafa Murat OZBALAK, Dilek Ozden OZLUK, Tarık Onur TIRYAKI, Beyza OLUK, Ipek YONAL HINDILERDEN, Mustafa Nuri YENEREL, Meliha NALCACI, Sevgi KALAYOGLU BESISIK, Sevda SERT EKINCI, Tufan TUKEK
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S52- (2021)
Objective: Patients with cancer are considered highly vulnerable to the COVID-19 disease. However, there are still few data in hematologic patients. Some small studies have shown a high mortality on patients with hematologic malignancies and COVID-19
Externí odkaz:
https://doaj.org/article/46923d1fb2504c958a9c7ce3a16c01f9
Autor:
Melda Sarıman, Neslihan Abacı, Sema Sırma Ekmekçi, Aris Çakiris, Ferda Perçin Paçal, Duran Üstek, Mesut Ayer, Mustafa Nuri Yenerel, Sevgi Beşışık, Kıvanç Çefle, Şükrü Palandüz, Şükrü Öztürk
Publikováno v:
Balkan Medical Journal, Vol 36, Iss 1, Pp 23-31 (2019)
Background: Multiple myeloma is a plasma cell dyscrasia characterized by transformation of B cells into malignant cells. Although there are data regarding the molecular pathology of multiple myeloma, the molecular mechanisms of the disease have not b
Externí odkaz:
https://doaj.org/article/6e465c95b66b417ab3cfbcd8bf7ca046
Autor:
Natalia Xavier S. de Andrade, MD, Suleyman Cem Adiyaman, MD, Bernamir De Yuksel, MD, Carla T. Ferrari, MD, Abdelwahab Jalal Eldin, MD, Basak Ozgen Saydam, MD, Canan Altay, MD, Pratima Sharma, MD, Nicole Bhave, MD, Ann Little, MD, Paul McKeever, MD, PhD, Huseyin Onay, MD, Sermin Ozkal, MD, Mustafa Secil, MD, Mustafa Nuri Yenerel, MD, Baris Akinci, MD, Elif A. Oral, MD
Publikováno v:
AACE Clinical Case Reports, Vol 6, Iss 2, Pp e79-e85 (2020)
ABSTRACT: Objective: Lipodystrophy represents a group of rare diseases characterized by loss of body fat. While patients with generalized lipodystrophy exhibit near-total lack of fat, partial lipodystrophy is associated with selective fat loss affect
Externí odkaz:
https://doaj.org/article/1bf7445361bc4ce8ba787fc77df4804a
Autor:
Derya Öztürk, Ender Mehmet Coşkunpınar, Emre Osmanbaşoğlu, Güven Çetin, Mustafa Nuri Yenerel, Mesut Ayer, Cumhur Gökhan Ekmekçi, Duran Üstek, Kıvanç Cefle, Şükrü Palanduz, Şükrü Öztürk
Publikováno v:
Haseki Tıp Bülteni, Vol 56, Iss 2, Pp 109-113 (2018)
Aim: Analysis of genes that play roles in multiple myeloma pathogenesis and their pathways are current research topics. We aimed to detect expression of some genes in ErbB and insulin signaling pathways. Methods: Bone marrow samples were taken f
Externí odkaz:
https://doaj.org/article/fdc561a15b584bcaaca0ca3849a9dad3
Autor:
Fehmi Hindilerden, Ipek Yönal Hindilerden, Mustafa Nuri Yenerel, Meliha Nalçacı, Reyhan Diz Küçükkaya
Publikováno v:
Turkish Journal of Hematology, Vol 34, Iss 1, Pp 72-80 (2017)
Objective: This paper prospectively evaluates the long-term followup [mean +- standard deviation (SD) duration: 89.7+-19.4 months] data of 15 patients (13 females and 2 males) with refractory symptomatic immune thrombocytopenia (ITP) treated with rit
Externí odkaz:
https://doaj.org/article/bcce001881d74681bd25f93dbdf58368